Trials / Conditions / Membranous Nephropathy - PLA2R Induced
Membranous Nephropathy - PLA2R Induced
5 registered clinical trials studyying Membranous Nephropathy - PLA2R Induced — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study NCT07163611 | Radboud University Medical Center | Phase 2 / Phase 3 |
| Recruiting | The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases NCT06285279 | Nanjing University School of Medicine | Phase 1 |
| Completed | Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy NCT05894512 | Istanbul University | — |
| Unknown | Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay) NCT05861869 | Zhejiang Biostar Biotechnology Co. | — |
| Recruiting | Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy NCT05679336 | St. Petersburg State Pavlov Medical University | N/A |